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The prevalence of this pathology in pregnant women 
is 24,8-1,2 cases in 35 thousand (0.76%). We have devised 
a method of providing specialized care for pregnant women 
with gastroduodenal bleeding of non-varicose origin.
Methods
In the third trimester, before endoscopic examination, in order 
to prevent premature birth, give patients an intravenous 
infusion of 10 mg hexoprenaline dissolved in 500 ml of 0.9% 
sodium chloride solution at a speed of 5-10 drops per minute, 
and administer an intramuscular injection of dexamethasone, 
as prevention of respiratory distress syndrome of the fetus, at 
a dose of 6 mg every 12 hours for 48 hours.
Thereafter perform endoscopy, establish the presence, 
location and character of the source of bleeding, and endo- 
scopically determ ine the state of local hemostasis in terms 
of the Forrest classification. Using the endoscopic tool, feed 
injector and at the source of bleeding inject 10-20ml of 0.9% 
sodium chloride and 1 ml of 0.18% solution of epinephrine.
Results
When we treated pregnant patients with gastroduodenal 
bleeding of non-varicose origin with the definitive treatment 
of endoscopic intervention, there was no gastrointestinal 
bleeding. In the comparison group of 15 women (observation 
period 2007 - 2011) endoscopic intervention for gastrointes­
tinal bleeding was carried out in 2 (13.3%) cases, with the 
further development of preeclampsia and severe preeclampsia, 
accompanied by antenatal fetal death.
445
